What is Pick's disease in older adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Pick's Disease?

Pick's disease is a specific neuropathological subtype of frontotemporal lobar degeneration (FTLD-tau) characterized by abnormal accumulation of 3-repeat tau protein forming distinctive intraneuronal inclusions called Pick bodies, primarily affecting the frontal and temporal lobes of the brain. 1

Neuropathological Definition

Pick's disease represents one of several tau protein pathologies that fall under the broader umbrella of frontotemporal lobar degeneration (FTLD-tau), which also includes progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). 1 The defining pathological features include:

  • Argyrophilic, round intraneuronal inclusions (Pick bodies) composed of abnormal tau proteins, most prominently found in the dentate fascia of the hippocampus 2
  • Circumscribed cortical atrophy predominantly affecting frontal and temporal poles, with neuronal loss maximal in limbic structures including hippocampus, entorhinal cortex, and amygdala 2
  • Ballooned cortical neurons (Pick cells) and pronounced glial reaction in affected gray and white matter 2
  • Tau-immunoreactive glial inclusions with a specific tau protein immunoblotting pattern distinct from Alzheimer's disease 2

Definitive diagnosis requires neuropathological confirmation through biopsy or autopsy; clinical diagnosis represents only the most likely etiology, not pathological certainty. 3

Clinical Presentations in Older Adults

Most Common Syndromes

Behavioral variant frontotemporal dementia (bvFTD) is the most common clinical presentation (57% of cases), characterized by progressive executive dysfunction, personality changes, and behavioral alterations with relative preservation of memory early in the disease course. 4 This distinguishes it from typical Alzheimer's disease. 3

Primary progressive aphasia (PPA) is the second most common presentation (33% of cases), typically manifesting as semantic variant or non-fluent variant PPA. 1, 4 When PPA is due to Pick's disease, it usually presents as semantic variant, though non-fluent variant can occur. 1

Atypical Presentations

Rare presentations include:

  • Corticobasal syndrome with asymmetric limb apraxia, rigidity, and cognitive dysfunction 1, 4
  • Amnestic dementia mimicking Alzheimer's disease with early memory impairment 5, 4
  • Progressive cortical cognitive-somatosensorimotor syndrome with executive dysfunction and asymmetric motor features 1

Age and Demographics

Pick's disease typically presents in the presenile period between ages 48-65 years and is rare after age 75. 3 The median age at disease onset is 54 years, with PPA cases presenting slightly earlier (median 52 years) than bvFTD cases (median 59 years). 4 The disease affects men and women equally. 6

Disease Course and Prognosis

Median disease duration from onset to death is 10 years, with no significant difference between bvFTD (9.5 years) and PPA (13 years) presentations. 4 The disease is progressive and incurable, with personality deterioration and memory deficits often more severe than the visuospatial and apraxic disorders common in Alzheimer's disease. 2

Mixed Pathology Considerations

A critical caveat: only one-third of clinically diagnosed Pick's disease cases show pure Pick pathology at autopsy. 4 The remaining two-thirds demonstrate coexistent pathologies including:

  • Alzheimer's disease pathology (29% of cases) 4
  • Cerebral amyloid angiopathy (14%) 4
  • Combined Alzheimer's and amyloid angiopathy (19%) 4
  • Lewy body disease (5%) 4

This is particularly relevant in older adults over age 80, where multiple brain pathologies are the rule rather than the exception. 1

Diagnostic Approach

The diagnostic approach is primarily clinical, requiring identification of a progressive dysexecutive and/or behavioral syndrome combined with neuroimaging showing characteristic frontal and temporal lobe atrophy, followed by exclusion of alternative etiologies. 3

Key Diagnostic Steps:

  • Non-contrast brain MRI is the primary imaging modality to identify characteristic atrophy patterns and exclude alternative diagnoses 3
  • FDG-PET/CT can differentiate frontotemporal dementia from Alzheimer's disease with 60% sensitivity and 78.5% positive predictive value, showing hypometabolism in frontal and/or temporal regions 3
  • Serial clinical assessments and repeat neuroimaging help confirm the progressive nature and refine diagnosis over time 3
  • Genetic counseling should be offered if autosomal dominant family history is present, as genetic predisposition is implicated in some cases 3, 6

Clinical Implications

Pick's disease accounts for approximately 5% of all dementias. 7 The most difficult aspects of care involve communication challenges as language deteriorates, requiring nurses and caregivers to adapt communication strategies continuously. 7 The disease is emotionally devastating to families, requiring comprehensive education about nutrition, skin protection, incontinence care, safety, and end-of-life decisions. 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pick's disease: a modern approach.

Brain pathology (Zurich, Switzerland), 1998

Guideline

Diagnostic Approach for Pick's Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A story of Pick's disease: a rare form of dementia.

The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.